- Clarification and consensus found with key stakeholders on outstanding elements
海角大神 (BHA) has today announced that the sport’s聽enhanced, zero-tolerance policy regarding the use of anabolic steroids聽is on course for implementation from Monday 2 March.
Confirmation of a March start date follows clarification and consensus being reached with聽the Racehorse Owners Association (ROA), National Trainers Federation (NTF) and Thoroughbred Breeders’ Association (TBA) on certain elements relating to the revised policy. These issues included聽the聽definition of 鈥渞esponsible person鈥, i.e.聽the individual with the responsibility for ensuring that a horse is not administered with an anabolic steroid, and led to a short delay in the policy’s introduction from January to March.
Jamie Stier, Director of Raceday Operations and Regulation for BHA, said:
鈥淭he implementation of an entirely new and far reaching set of聽anti-doping聽Rules聽has been a聽complex process.聽We thank the ROA, NTF and TBA for their input throughout this process and their support for the principles behind the enhanced policy and the decision to delay the implementation.
鈥淲e are naturally pleased to have reached consensus with all parties regarding the outstanding issues聽and, while it was disappointing not to implement the policy on 1 January, it was certainly the right decision not to rush the introduction of the Rules until consensus was reached.鈥
The聽policy, first announced in June 2014,聽has the objective of ensuring that British Racing remains at the forefront of聽tackling聽an issue that ranks amongst the biggest threats faced by all international sports.聽Key pillars in the聽policy聽include: that a racehorse must never be administered with an anabolic steroid at any time from birth to retirement; greater powers for BHA in terms of access for testing registered horses; the requirement for horses to be registered from a younger age and for BHA to be aware of their whereabouts at all times; a more stringent 14 months stand-down period for horses found to have been administered with anabolic steroids; and greater controls on horses running in Great Britain from international jurisdictions.
More details regarding the implementation of the new Rules will be published in due course 鈥 ahead of the implementation date 鈥 and will include guidance to affected parties regarding how to ensure adherence to the new Rules.
Attached documents
Notes to Editors
- Full details of the Policy are attached to this press release.
- Details of the initial announcement of the Policy in June can be found here: /press_releases/bha-announces-zero-tolerance-policy-towards-anabolic-steroids/
- The release which announced the decision to delay the implementation can be found here:/press_releases/implementation-new-anabolic-steroids-policy-delayed-march/
- The Rules apply not only to anabolic steroids but all substances and methods which fall into these categories:
- Anabolic agents;
- Non-approved substances;
- Peptide hormones, growth factors and related substances;
- Hormone and metabolic modulators;
- Manipulation of blood and blood components;
- Blood transfusions;
- Genetic and cellular manipulation;
- Oxygen carriers.
- The IFHA minimum standard states that:
- IFHA considers that anabolic steroids have no place in horseracing
- The use of anabolic steroids should not be permitted in or out of competition
- IFHA will work with jurisdictions that may permit exceptional use for therapeutic purposes only, subject to stringent controls and a minimum stand down period to eliminate performance enhancing effects.